SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 23, 12:20
594.75
0.15 (0.03%)
VOLUME 89,460
LIVE
NSE
Sep 23, 12:20
593.60
-0.85 (-0.14%)
VOLUME 678,792
Announcements on Ranbaxy Labs

17th-Sep-2014 17:44Source: NSE

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited has informed the Exchange that the Company has received a Civil Investigative Demand ("CID") from the United States Department of Justice relating to the manner in which i...

17th-Sep-2014 17:04Source: BSE

Ranbaxy Labs- Receipt of Civil Investigative Demand ("CID") from the United States Department of Justice

Ranbaxy Laboratories Ltd has informed BSE that the Company has received a Civil Investigative Demand ("CID") from the United States Department of Justice relating to the manner in which it reports pri...

16th-Sep-2014 18:40Source: NSE

Ranbaxy Laboratories Limited

The Exchange had sought clarifiation from Ranbaxy Laboratories Limited with respect to a news item captioned "Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor". The Company has clarified ...

2nd-Sep-2014 11:26Source: NSE

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited has submitted to the Exchange vide letter dated September 2, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider T...

2nd-Sep-2014 11:06Source: BSE

Ranbaxy Labs- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Ranbaxy Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

28th-Aug-2014 10:27Source: BSE

Ranbaxy Labs- Communication received from the Competition Commission of India in respect of the proposed combination between the Company and Sun Pharmaceutical Industries Ltd.

Ranbaxy Laboratories Ltd has informed BSE that the Company has received direction vide letter dated August 27, 2014 under Section 29(2) of the Competition Act, 2002 from the Competition Commission of ...

28th-Aug-2014 08:58Source: NSE

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited has informed the Exchange that the Company has received direction vide letter dated August 27, 2014 under Section 29(2) of the Competition Act, 2002 from the Competition C...

25th-Aug-2014 13:04Source: BSE

Ranbaxy Labs- Clarification from Ranbaxy Laboratories Ltd

The Exchange had sought clarification with respect to the media report "Ranbaxy faces Rs.242 Crores fine in US for violations at Toansa" appearing in Business Standard on August 22, 2014.

Ranba...

25th-Aug-2014 12:40Source: NSE

Ranbaxy Laboratories Limited

The Exchange had sought clarification from Ranbaxy Laboratories Limited with respect to a news item captioned "Ranbaxy faces Rs 242 cr fine in US for violations at Toansa". The Company has clarified t...

22nd-Aug-2014 15:36Source: BSE

Ranbaxy Labs- Court Convened Meeting of the Equity Shareholders of the Company on Sep 19, 2014

Ranbaxy Laboratories Ltd has informed BSE that Pursuant to an Order dated August 05, 2014, the Honb’le High Court of Punjab and Haryana at Chandigarh has directed that a meeting of the Equity Shareh...

1 2 3 4 5 Next >>
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.